Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$6.53 USD
+0.01 (0.15%)
Updated Jul 17, 2024 04:00 PM ET
After-Market: $6.51 -0.02 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.79 | 0.00% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-0.89 per share. This reflects a positive earnings surprise of 11.24%. Look out for SYRS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.79 per share, reflecting a year-over-year increase of 39.23%.
Earnings History
Price & Consensus
Zacks News for SYRS
2seventy bio, Inc. (TSVT) Reports Q1 Loss, Tops Revenue Estimates
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services